Standout Papers
- Optimizing ethambutol dosing among HIV/tuberculosis co-infected patients: a population pharmacokinetic modelling and simulation study (2019)
- Early Versus Delayed Antiretroviral Therapy and Cerebrospinal Fluid Fungal Clearance in Adults With HIV and Cryptococcal Meningitis (2013)
- Upregulation of the Phthiocerol Dimycocerosate Biosynthetic Pathway by Rifampin-Resistant,rpoBMutant Mycobacterium tuberculosis (2012)
- Immunological profiling of tuberculosis-associated immune reconstitution inflammatory syndrome and non-immune reconstitution inflammatory syndrome death in HIV-infected adults with pulmonary tuberculosis starting antiretroviral therapy: a prospective observational cohort study (2015)
- Markers of gut dysfunction do not explain low rifampicin bioavailability in HIV-associated TB (2017)
- A Common NLRC4 Gene Variant Associates With Inflammation and Pulmonary Function in Human Immunodeficiency Virus and Tuberculosis (2019)
- Isoniazid clearance is impaired among human immunodeficiency virus/tuberculosis patients with high levels of immune activation (2016)
- Robust Reconstitution of Tuberculosis-Specific Polyfunctional CD4+T-Cell Responses and Rising Systemic Interleukin 6 in Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome (2015)
- Common Variation in NLRP3 Is Associated With Early Death and Elevated Inflammasome Biomarkers Among Advanced HIV/TB Co-infected Patients in Botswana (2018)
- Matrix Metalloproteinases in Tuberculosis-Immune Reconstitution Inflammatory Syndrome and Impaired Lung Function Among Advanced HIV/TB Co-infected Patients Initiating Antiretroviral Therapy (2015)
- Tuberculosis and lung damage: from epidemiology to pathophysiology (2018)
- Elevated Pre–Antiretroviral Therapy CD39+CD8+ T Cell Frequency Is Associated With Early Mortality in Advanced Human Immunodeficiency Virus/Tuberculosis Co-infection (2017)
- Pyrazinamide clearance is impaired among HIV/tuberculosis patients with high levels of systemic immune activation (2017)
- Declines in Lung Function After Antiretroviral Therapy Initiation in Adults With Human Immunodeficiency Virus and Tuberculosis: A Potential Manifestation of Respiratory Immune Reconstitution Inflammatory Syndrome (2019)
- Early Immunologic Failure is Associated With Early Mortality Among Advanced HIV–Infected Adults Initiating Antiretroviral Therapy With Active Tuberculosis (2013)
- Effect of GB virus C viremia on HIV acquisition and HIV set-point (2005)
- Lung Injury on Antiretroviral Therapy in Adults With Human Immunodeficiency Virus/Tuberculosis (2019)
Citation Impact
Citing Papers
Global increase and geographic convergence in antibiotic consumption between 2000 and 2015
2018 Standout
Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Predictors of Mortality in Patients with Bloodstream Infections Caused by Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae : Importance of Inadequate Initial Antimicrobial Treatment
2007
Interventions to improve antibiotic prescribing practices for hospital inpatients
2017 Standout
Serial measurement of M. tuberculosis in blood from critically-ill patients with HIV-associated tuberculosis
2022 StandoutNobel
Deep Patient: An Unsupervised Representation to Predict the Future of Patients from the Electronic Health Records
2016 Standout
Multi-level predictors of psychological problems among methadone maintenance treatment patients in difference types of settings in Vietnam
2019
Adult meningitis in a setting of high HIV and TB prevalence: findings from 4961 suspected cases
2010
Mycobacteriophage SWU1 gp39 can potentiate multiple antibiotics against Mycobacterium via altering the cell wall permeability
2016
The re-emergence of natural products for drug discovery in the genomics era
2015 Standout
Impact of Treatment Strategy on Outcomes in Patients with Candidemia and Other Forms of Invasive Candidiasis: A Patient-Level Quantitative Review of Randomized Trials
2012 Standout
A Hospitalwide Intervention Program to Optimize the Quality of Antibiotic Use: Impact on Prescribing Practice, Antibiotic Consumption, Cost Savings, and Bacterial Resistance
2003
Risk Factors for the Development of Extended-Spectrum Beta-Lactamase-Producing Bacteria in Nonhospitalized Patients
2004
Patient Retention in Antiretroviral Therapy Programs in Sub-Saharan Africa: A Systematic Review
2007
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
2009 Standout
Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis
2017 Standout
Pseudomonas Aeruginosa: Resistance to the Max
2011 Standout
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
2011 Standout
Network pharmacology: the next paradigm in drug discovery
2008 Standout
Management of Cryptococcal Meningitis in Sub-Saharan Africa
2010
Evaluation of a Novel Point-of-Care Cryptococcal Antigen Test on Serum, Plasma, and Urine From Patients With HIV-Associated Cryptococcal Meningitis
2011
Effect of early and late GB virus C viraemia on survival of HIV‐infected individuals: a meta‐analysis
2006
Management of Inpatients Colonized or Infected With Antimicrobial-Resistant Bacteria in Hospitals in the United States
2005
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
2008 Standout
Interventions to increase antiretroviral adherence in sub-Saharan Africa: a systematic review of evaluation studies
2011
Aerosol Generating Procedures and Risk of Transmission of Acute Respiratory Infections to Healthcare Workers: A Systematic Review
2012 Standout
Inhibitors of VIM-2 by screening pharmacologically active and click-chemistry compound libraries
2009 StandoutNobel
Successes, challenges, and limitations of current antiretroviral therapy in low-income and middle-income countries
2009
Bad Bugs Need Drugs: An Update on the Development Pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America
2006 Standout
Cause‐Specific Mortality and the Contribution of Immune Reconstitution Inflammatory Syndrome in the First 3 Years after Antiretroviral Therapy Initiation in an Urban African Cohort
2009
The growing burden of antimicrobial resistance
2008
Mobile phone technologies improve adherence to antiretroviral treatment in a resource-limited setting: a randomized controlled trial of text message reminders
2011 Standout
Hospital-Based Strategies for Combating Resistance
2006
A Systematic Review of Quasi-Experimental Study Designs in the Fields of Infection Control and Antibiotic Resistance
2005
Interventions to improve antibiotic prescribing practices for hospital inpatients
2013 Standout
A neglected epidemic: fungal infections in HIV/AIDS
2014
Carbapenem-Resistant Enterobacteriaceae: Epidemiology and Prevention
2011 Standout
Screening for Extended-Spectrum -Lactamase-Producing Enterobacteriaceae among High-Risk Patients and Rates of Subsequent Bacteremia
2007
The end of AIDS: HIV infection as a chronic disease
2013 Standout
Cryptococcal meningitis screening and community-based early adherence support in people with advanced HIV infection starting antiretroviral therapy in Tanzania and Zambia: an open-label, randomised controlled trial
2015
Development of a set of multiplex PCR assays for the detection of genes encoding important β-lactamases in Enterobacteriaceae
2010 Standout
Novel paradigms for drug discovery: computational multitarget screening
2008
Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern
2008 Standout
Artificial Intelligence in Cardiology
2018 Standout
Assessing the Viorologic and Adherence Benefits of Patient-Selected HIV Treatment Partners in a Resource-limited Setting
2010
Control of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a children's hospital by changing antimicrobial agent usage policy
2007
Transmission of COVID-19 virus by droplets and aerosols: A critical review on the unresolved dichotomy
2020 Standout
Response to the AIDS Pandemic — A Global Health Model
2013
Control of extended-spectrum -lactamase-producing Klebsiella pneumoniae using a computer-assisted management program to restrict third-generation cephalosporin use
2008
Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum β-lactamase producing, Enterobacteriaceae infections: a systematic review
2009 Standout
Herpes Zoster
2013 Standout
HIV Viral Load Monitoring in Resource‐Limited Regions: Optional or Necessary?
2006
Clinical, microbiologic, and immunologic determinants of mortality in hospitalized patients with HIV-associated tuberculosis: A prospective cohort study
2019
Poor long-term outcomes for cryptococcal meningitis in rural South Africa
2011
Invasive Methicillin-Resistant <EMPH TYPE="ITAL">Staphylococcus aureus</EMPH> Infections in the United States
2007 Standout
Management of multidrug-resistant organisms in health care settings, 2006
2007
Xpert Ultra testing of blood in severe HIV-associated tuberculosis to detect and measure Mycobacterium tuberculosis blood stream infection: a diagnostic and disease biomarker cohort study
2022
Longitudinal Antiretroviral Adherence in HIV+ Ugandan Parents and Their Children Initiating HAART in the MTCT-Plus Family Treatment Model: Role of Depression in Declining Adherence Over Time
2009
Long term outcomes of antiretroviral therapy in a large HIV/AIDS care clinic in urban South Africa: a prospective cohort study
2009
epic3: National Evidence-Based Guidelines for Preventing Healthcare-Associated Infections in NHS Hospitals in England
2013 Standout
The New β-Lactamases
2005
Bloodstream Infections Caused by Extended-Spectrum-β-Lactamase-Producing Klebsiella pneumoniae : Risk Factors, Molecular Epidemiology, and Clinical Outcome
2006
Mechanisms of Antibiotic Resistance
2016 Standout
Carbapenemases: the Versatile β-Lactamases
2007 Standout
Global and Multi-National Prevalence of Fungal Diseases—Estimate Precision
2017 Standout
Visualization of mycobacterial membrane dynamics in live cells
2017 StandoutNobel
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
Deep learning for healthcare: review, opportunities and challenges
2017 Standout
Extended-Spectrum β-Lactamases: a Clinical Update
2005 Standout
Risk Factors for and Outcomes of Bloodstream Infection Caused by Extended-Spectrum β-Lactamase–Producing Escherichia coli and Klebsiella Species in Children
2005
Viral suppression after 12 months of antiretroviral therapy in low- and middle-income countries: a systematic review
2013
The Use of Functional Genomics in Conjunction with Metabolomics forMycobacterium tuberculosisResearch
2014
Three Decades of β-Lactamase Inhibitors
2010 Standout
Interventions for enhancing medication adherence
2014 Standout
2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings
2007 Standout
Immediate Psychological Responses and Associated Factors during the Initial Stage of the 2019 Coronavirus Disease (COVID-19) Epidemic among the General Population in China
2020 Standout
Point-of-Care Diagnostics for Global Health
2008 Standout
Community-Associated Methicillin-ResistantStaphylococcus aureus: Epidemiology and Clinical Consequences of an Emerging Epidemic
2010 Standout
Clinical Practice Guideline for the Diagnosis and Management of Group A Streptococcal Pharyngitis: 2012 Update by the Infectious Diseases Society of America
2012 Standout
The return of metabolism: biochemistry and physiology of the pentose phosphate pathway
2014 Standout
Hidden Killers: Human Fungal Infections
2012 Standout
The Epidemiology of Carbapenem-Resistant Enterobacteriaceae: The Impact and Evolution of a Global Menace
2017 Standout
Global Challenge of Multidrug-ResistantAcinetobacter baumannii
2007 Standout
Characterization of an Immunodominant Antigenic Site on GB Virus C Glycoprotein E2 That Is Involved in Cell Binding
2006 StandoutNobel
Evaluation of screening and treatment of cryptococcal antigenaemia among HIV ‐infected persons in S oweto, S outh A frica
2015
Antimicrobial Resistance in ESKAPE Pathogens
2020 Standout
Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Guidelines for Developing an Institutional Program to Enhance Antimicrobial Stewardship
2006 Standout
Identification of type 2 diabetes subgroups through topological analysis of patient similarity
2015
Works of Gregory P. Bisson being referenced
Early Versus Delayed Antiretroviral Therapy and Cerebrospinal Fluid Fungal Clearance in Adults With HIV and Cryptococcal Meningitis
2013 StandoutNobel
Antiretroviral Failure Despite High Levels of Adherence: Discordant Adherence-Response Relationship in Botswana
2008
Elevated Pre–Antiretroviral Therapy CD39+CD8+ T Cell Frequency Is Associated With Early Mortality in Advanced Human Immunodeficiency Virus/Tuberculosis Co-infection
2017 StandoutNobel
Diagnostic accuracy of CD4 cell count increase for virologic response after initiating highly active antiretroviral therapy
2006
Early Immunologic Failure is Associated With Early Mortality Among Advanced HIV–Infected Adults Initiating Antiretroviral Therapy With Active Tuberculosis
2013 StandoutNobel
Effect of GB virus C viremia on HIV acquisition and HIV set-point
2005 StandoutNobel
Immunological profiling of tuberculosis-associated immune reconstitution inflammatory syndrome and non-immune reconstitution inflammatory syndrome death in HIV-infected adults with pulmonary tuberculosis starting antiretroviral therapy: a prospective observational cohort study
2015 StandoutNobel
Out-of-pocket costs of HAART limit HIV treatment responses in Botswana's private sector
2006
The Use of HAART Is Associated With Decreased Risk of Death During Initial Treatment of Cryptococcal Meningitis in Adults in Botswana
2008
Extended-Spectrum β-Lactamase–ProducingEscherichia coliandKlebsiellaSpecies: Risk Factors for Colonization and Impact of Antimicrobial Formulary Interventions on Colonization Prevalence
2002
Overestimates of Survival after HAART: Implications for Global Scale-Up Efforts
2008
Early Mortality in Adults Initiating Antiretroviral Therapy (ART) in Low- and Middle-Income Countries (LMIC): A Systematic Review and Meta-Analysis
2011
HIV infection and glycemic response to newly initiated diabetic medical therapy
2012
Common Variation in NLRP3 Is Associated With Early Death and Elevated Inflammasome Biomarkers Among Advanced HIV/TB Co-infected Patients in Botswana
2018 StandoutNobel
Cryptococcus and lymphocytic meningitis in Botswana.
2008
Pharmacy Refill Adherence Compared with CD4 Count Changes for Monitoring HIV-Infected Adults on Antiretroviral Therapy
2008
Upregulation of the Phthiocerol Dimycocerosate Biosynthetic Pathway by Rifampin-Resistant,rpoBMutant Mycobacterium tuberculosis
2012 StandoutNobel